Tens of millions of contrast-enhanced magnetic resonance imaging (MRI) exams are
performed annually around the world. The contrast agents, which improve diagnostic …

Research on bimodal contrast agents in general and optical/MRI contrast agents in
particular has attracted increased attention from the scientific community in recent years …

Materials for Biomedical Engineering: Inorganic Micro-and Nanostructures presents recent,
specific insights in new progress, along with new perspectives for inorganic micro-and nano …

It has been demonstrated that divalent zinc ions packaged with insulin in β-cell granules can
be detected by MRI during glucose-stimulated insulin secretion using a gadolinium-based …

Given the known water exchange rate limitations of a previously reported Zn (II)-sensitive
MRI contrast agent, GdDOTA-diBPEN, new structural targets were rationally designed to …

Alzheimer's disease (AD) is the most prevalent illness among the neurodegenerative
disorders that are progressive, irreversible and incurable so far. Although the etiological …

Alzheimer's disease (AD) is currently an incurable neurodegenerative disorder that affects
millions of people around the world. The aggregation of amyloid-β peptides (Aβ), one of the …

Protein aggregation has been widely implicated in neurodegenerative diseases such as
Alzheimer's disease, frontotemporal dementia, Parkinson's disease, and Huntington …

The convergent synthesis and characterization of a potential theranostic agent,[DPP‐ZnP‐
GdDOTA]−, which combines a diketopyrrolopyrrole‐porphyrin component DPP‐ZnP as a …

A new potential ZnII responsive MnII-based MRI CA candidate derived from pyclen-3, 9-
diacetate (3, 9-PC2A) has been synthesized and it possesses a di-(2-picolyl) amine (DPA) …